MedTrace Logo

Post Market Study Using the Xoft Axxent System

NCT01017549 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2020-08-13

Study results available
· View outcomes & findings →

Summary

The purpose of this multi-center clinical study is to compile post market performance and safety data on the Axxent System.

Conditions

Interventions

RADIATION

Electronic brachytherapy (Axxent System)

3.4 Gy per fraction for 10 fractions for a total of 34 Gy.

Sponsors & Collaborators

  • Xoft, Inc.

    lead INDUSTRY

Principal Investigators

  • Vivek K Mehta, MD · Swedish Cancer Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-26
Primary Completion
2013-06-06
Completion
2016-05-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01017549 on ClinicalTrials.gov